IFF Accelerates Portfolio Shift: $4.3 Billion Food Ingredients Sale Agreed with CVC Capital Partners

International Flavors & Fragrances (IFF) has taken a significant step in reshaping its strategic focus, entering into a definitive agreement to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, while retaining a 10 % minority equity interest valued around $200 million.

The transaction, announced on May 29, 2026, values the Food Ingredients division at an enterprise value-to-EBITDA multiple of roughly 10 times. As part of the deal, IFF will continue collaborating with the business under its new ownership, maintaining potential upside from future value creation. The agreement is expected to close by the end of Q2 2027, pending regulatory approvals and customary closing conditions.

This move comes amid IFF’s broader portfolio optimization strategy, which includes prior divestitures such as the completion of the SCL (Soy Crush, Concentrates, and Lecithin) businesses earlier in March 2026. With Food Ingredients and SCL now classified as discontinued operations, IFF is directing its attention to its higher-growth, higher-margin segments—Taste, Scent, and Health & Biosciences.

The company’s Q2 2026 results underscore this strategic realignment: on a continuing operations basis, excluding discontinued operations, IFF expects full-year sales of $7.4 billion to $7.6 billion and adjusted operating EBITDA of $1.53 billion to $1.60 billion. The divestiture proceeds will also fund enhanced shareholder returns, including a $2.0 billion remaining share buyback authorization, expected to be executed post-close and completed by the end of 2027.

For shareholders and investors, the Food Ingredients divestiture marks a clear pivot toward streamlining operations and enhancing balance sheet flexibility. By shed low-margin assets and concentrating on innovation-led categories, IFF aims to reinforce profitability and growth momentum.

Looking forward, investors will be watching for regulatory milestones and approval progress as IFF moves toward closing the transaction. Following the completion, how the company deploys the proceeds—whether through buybacks, debt reduction, or reinvestment—will be central to evaluating the effectiveness of this strategic shift.

Ultimately, this divestiture is a material development—rooted in verified filings and confirmed press announcements—that concretely advances IFF’s ambition to become a leaner, higher-margin leader in flavors, scents, and biosciences.

Stock Note: As of October 2, 2026, IFF shares are trading at $82.42, down 1.69 %. This price reflects broader market factors and should not be assumed to result directly from the Food Ingredients transaction.